We recommend development of a clinical assay for the replication recovery defect and for NSMCE3 mutations and consideration of this disorder for children with unexplained, rapid pulmonary failure following multiple virus-induced pneumonias. This evidence concerns the gene NSMCE3 and pneumonia.